MULTI-SEGMENT INJECTION-CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRY (MSI-CE-MS): A MULTIPLEXED SCREENING PLATFORM AND DATA WORKFLOW FOR CHEMICAL ANALYSIS
    1.
    发明申请
    MULTI-SEGMENT INJECTION-CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRY (MSI-CE-MS): A MULTIPLEXED SCREENING PLATFORM AND DATA WORKFLOW FOR CHEMICAL ANALYSIS 有权
    多部门注射 - 电泳 - 质谱(MSI-CE-MS):化学分析的多层筛选平台和数据工作流程

    公开(公告)号:US20160086780A1

    公开(公告)日:2016-03-24

    申请号:US14891084

    申请日:2014-05-14

    Abstract: Various embodiments illustrating a multiplexed method for high throughput screening of ions in biological samples within a single capillary when using capillary electrophoresis mass spectrometry (CE-MS) are illustrated. The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis (CE) run. The method also includes application of voltage to the single capillary subsequent to sequential injection and zonal separation of polar metabolites within each sample segment by CE such that each analyte zone migrates within its characteristic electrophoretic mobility offset in time by the spacer. The incorporation of a quality control/reference sample and the use of dilution patterning with specific injection configurations also enables encoding of information temporally for enhanced data processing with quality assurance.

    Abstract translation: 示出了当使用毛细管电泳质谱(CE-MS)时,单个毛细管内的生物样品中离子生物样品的高通量筛选的多路复用方法。 该方法包括在单个毛细管内连续注射多个样品片段,样品片段由缓冲液的间隔塞隔开,并在单个毛细管电泳(CE)运行中同时对样品片段进行多重分析。 该方法还包括在CE之间顺序注射和每个样品区段内的极性代谢物的区域分离之后,向单个毛细管施加电压,使得每个分析物区域在其特征电泳迁移率偏移期间通过间隔物在时间上迁移。 质量控制/参考样品的并入以及使用具有特定注射配置的稀释图案化也可以使信息在时间上进行编码,从而提高质量保证的数据处理能力。

    Multi-segment injection-capillary electrophoresis-mass spectrometry (MSI-CE-MS): a multiplexed screening platform and data workflow for chemical analysis
    2.
    发明授权
    Multi-segment injection-capillary electrophoresis-mass spectrometry (MSI-CE-MS): a multiplexed screening platform and data workflow for chemical analysis 有权
    多段注射 - 毛细管电泳 - 质谱(MSI-CE-MS):化学分析的复用筛选平台和数据流程

    公开(公告)号:US09490110B2

    公开(公告)日:2016-11-08

    申请号:US14891084

    申请日:2014-05-14

    Abstract: Various embodiments illustrating a multiplexed method for high throughput screening of ions in biological samples within a single capillary when using capillary electrophoresis mass spectrometry (CE-MS) are illustrated. The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis (CE) run. The method also includes application of voltage to the single capillary subsequent to sequential injection and zonal separation of polar metabolites within each sample segment by CE such that each analyte zone migrates within its characteristic electrophoretic mobility offset in time by the spacer. The incorporation of a quality control/reference sample and the use of dilution patterning with specific injection configurations also enables encoding of information temporally for enhanced data processing with quality assurance.

    Abstract translation: 示出了当使用毛细管电泳质谱(CE-MS)时,单个毛细管内的生物样品中离子生物样品的高通量筛选的多路复用方法。 该方法包括在单个毛细管内连续注射多个样品片段,样品片段由缓冲液的间隔塞隔开,并在单个毛细管电泳(CE)运行中同时对样品片段进行多重分析。 该方法还包括在CE之间顺序注射和每个样品区段内的极性代谢物的区域分离之后,向单个毛细管施加电压,使得每个分析物区域在其特征电泳迁移率偏移期间通过间隔物在时间上迁移。 质量控制/参考样品的并入以及使用具有特定注射配置的稀释图案化也可以使信息在时间上进行编码,从而提高质量保证的数据处理能力。

    Allosteric activators for treatment of phenylketonuria

    公开(公告)号:US10426751B2

    公开(公告)日:2019-10-01

    申请号:US15542225

    申请日:2016-01-08

    Abstract: A method of restoring activity in phenylalanine hydroxylase is provided. The method comprises exposing the phenylalanine hydroxylase to shikimic acid, a functionally equivalent analog thereof, a pharmaceutically acceptable salt of shikimic acid or analog thereof, or combinations thereof. A method of screening for allosteric activators for a target enzyme is also provided comprising the steps of: denaturing the target enzyme with a first chaotropic agent to yield denatured enzyme, incubating the denatured enzyme with a candidate compound under denaturing conditions to allow enzyme refolding, and assaying enzyme activity in the presence of enzyme substrate and a candidate compound; and if enzyme activity of the denatured enzyme was restored in step i) by at least about 10% of residual enzyme activity, denaturing the target enzyme with a second chaotropic agent to yield denatured enzyme, incubating the denatured enzyme with the candidate compound under non-denaturing conditions to allow enzyme refolding, and assaying enzyme activity in the presence of enzyme substrate and the candidate compound, wherein an increase in enzyme activity of at least about 10% of residual enzyme activity indicates that the candidate compound is an allosteric activator of the target enzyme.

    ALLOSTERIC ACTIVATORS FOR TREATMENT OF PHENYLKETONURIA

    公开(公告)号:US20180064672A1

    公开(公告)日:2018-03-08

    申请号:US15542225

    申请日:2016-01-08

    Abstract: A method of restoring activity in phenylalanine hydroxylase is provided. The method comprises exposing the phenylalanine hydroxylase to shikimic acid, a functionally equivalent analogue thereof, a pharmaceutically acceptable salt of shikimic acid or analogue thereof, or combinations thereof. A method of screening for allosteric activators for a target enzyme is also provided comprising the steps of: denaturing the target enzyme with a first chaotropic agent to yield denatured enzyme, incubating the denatured enzyme with a candidate compound under denaturing conditions to allow enzyme refolding, and assaying enzyme activity in the presence of enzyme substrate and a candidate compound; and if enzyme activity of the denatured enzyme was restored in step i) by at least about 10% of residual enzyme activity, denaturing the target enzyme with a second chaotropic agent to yield denatured enzyme, incubating the denatured enzyme with the candidate compound under non-denaturing conditions to allow enzyme refolding, and assaying enzyme activity in the presence of enzyme substrate and the candidate compound, wherein an increase in enzyme activity of at least about 10% of residual enzyme activity indicates that the candidate compound is an allosteric activator of the target enzyme.

    Method of Diagnosing and Treatment Monitoring of Crohn's Disease and Ulcerative Colitis

    公开(公告)号:US20230015257A1

    公开(公告)日:2023-01-19

    申请号:US17784979

    申请日:2020-12-13

    Abstract: Methods of diagnosing Crohn’s disease and ulcerative colitis in subjects is provided based on the determination of metabolites in urine samples, such as serine, hypoxanthine, kynurenine, threonine, dimethylglycine, tryptophan, indoxylsul-fate, phenylacetylglutamine, sialic acid, 5-hydroxy-6-indolyl-o-sulfate, 5-(Δ-carboxybutyl) homocysteine, and/or an anion having m/ z:RMT:polarity of 345.1553:0.770:n, or determination of metabolites in stool samples, such as ketodeoxycholic acid, cholic acid, choline, tryptophan, trimethyllysine, serine, butyric acid, lactic acid, hypoxanthine and/or guanine.

Patent Agency Ranking